Our Research

Explainer: Waymark’s Impact on Patient Care and Cost Savings

Simulating A/B testing versus SMART designs for LLM-driven patient engagement to close preventive care gaps

Our 2023 Year in Review: Sharing First-Year Results and What’s to Come

Transforming Medicaid: A Blueprint for Equitable Care

A new book by Waymark co-founder and Head of Clinical Sanjay Basu examines the history of Medicaid and offers a path forward toward long-term solutions that deliver more equitable, high-value care.

The Risk of Perpetuating Health Disparities through Cost-Effectiveness Assessments

In a new peer-reviewed study just published in Health Affairs, Waymark co-founder and Head of Clinical Sanjay Basu and co-authors at the University of Pennsylvania and University of California San Francisco explore how cost-effective analyses—one of the most commonly used tools to evaluate health interventions—may risk perpetuating health disparities.

From Veneers To Value: Data Science Can Enable High-Value Care In Medicaid

In a new article for Health Affairs, Waymark co-founders Rajaie Batniji and Sanjay Basu and VP of Data Science and AI Sadiq Patel discuss how data quality issues and insufficient integration of clinical and social risk factor data have limited the ability of Medicaid programs to proactively identify and deliver targeted interventions to at-risk patients.

Recap: AcademyHealth Annual Research Meeting

Waymark’s Data Science team, led by Sadiq Patel and Bhairavi Muralidharan, were in attendance at Academy Health's Annual Research Meeting. These are their top takeaways.

Reaching Patients in the Critical Moment: Waymark’s Approach to AI & Rising Risk

For many rising risk patients, there is often a critical window of time to reach and engage them before their health changes for the worse — and they end up in the ED or hospital as a result. Rather than focusing solely on addressing the needs of high-cost claimants, we prioritize reaching and engaging rising risk patients before they cross into that category.

New Study Shows Industry-Leading Performance for Waymark Signal

Peer-reviewed study demonstrates Waymark Signal is 90 percent accurate in predicting avoidable ER and hospital visits

The Randomized Trials That Underpin Waymark's Care Model

Randomized controlled trials (RCTs) are the gold standard for identifying the strongest evidence for clinical practice. At Waymark, we rely on rigorous RCTs to define the detailed protocols and processes we deploy as our care model.